School of Health Policy & Management, York University, Toronto, Ontario, Canada.
Programs in History and Environment & Society, School of Humanities & Languages, University of New South Wales, Sydney, New South Wales, Australia.
Int J Health Serv. 2020 Jul;50(3):292-298. doi: 10.1177/0020731420912999. Epub 2020 Mar 25.
Previous studies have demonstrated a sex bias when it comes to the portrayal of men and women in medical journal advertisements for prescription drugs for psychiatric conditions. However, these studies have typically looked at ads over a restricted time period and often for a single diagnosis. Here we focus on ads for 3 diagnoses - anxiety, depression, and a combination of anxiety and depression - and cover nearly half a century to examine how the portrayal of patients changed over that time period with respect to sex. We sampled ads for products treating anxiety, depression, and anxiety/depression published in the between 1946 and 1990. Our findings confirm other studies showing a marked preponderance of female patient representation during the 1960s in psychotropic drug advertising. However, we also show that from the mid-1970s to the mid-1980s, the proportion of ads for drugs featuring depression and/or anxiety indications depicted male patients significantly more than prior years in which females predominated, demonstrating advertisers' reaction to the critique of gender stereotyping.
先前的研究表明,在医学期刊上刊登的处方精神疾病药物广告中,男性和女性的形象刻画存在性别偏见。然而,这些研究通常只关注了有限的时间内的广告,而且往往针对单一的诊断。在这里,我们关注了针对焦虑、抑郁和焦虑/抑郁这三种诊断的广告,并涵盖了近半个世纪的时间,以研究在这段时间内,患者的性别形象如何发生变化。我们从 1946 年至 1990 年期间在《新英格兰医学杂志》上刊登的治疗焦虑、抑郁和焦虑/抑郁的产品广告中抽取了样本。我们的研究结果证实了其他研究的发现,即在精神药物广告中,20 世纪 60 年代女性患者的代表性明显占主导地位。然而,我们还发现,从 20 世纪 70 年代中期到 80 年代中期,与之前女性主导的时期相比,广告中描述抑郁和/或焦虑症状的药物广告中男性患者的比例显著增加,这表明广告商对性别刻板印象的批评做出了反应。